Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Although growth hormone (GH) replacement therapy is increasingly utilized in the management of adult hypopituitary patients, optimum dosing schedules are poorly defined. The use of weight-based or surface area-based dosing may result in overtreatment, and individual variation in susceptibility on th...
主要な著者: | Drake, WM, Coyte, D, Camacho-Hübner, C, Jivanji, N, Kaltsas, G, Wood, D, Trainer, P, Grossman, AB, Besser, G, Monson, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1998
|
類似資料
-
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
著者:: Florakis, D, 等
出版事項: (2000) -
Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
著者:: Monson, J, 等
出版事項: (2001) -
Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
著者:: Frajese, G, 等
出版事項: (2001) -
Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
著者:: Chung, T, 等
出版事項: (2008) -
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
著者:: Agha, A, 等
出版事項: (2007)